Shield Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2020
April 29, 2021 at 02:00 am EDT
Shield Therapeutics plc announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was GBP 10.387 million compared to GBP 719,000 a year ago. Operating loss was GBP 2.154 million compared to GBP 9.035 million a year ago. Net loss was GBP 2.630 million compared to GBP 8.800 million a year ago. Basic loss per share from continuing operations was GBP 0.02 compared to GBP 0.08 a year ago.